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Abstract
Background: Hospital-based surveillance for pneumococcal meningitis has been conducted since January 1996 in the
city of Salvador, Brazil. The purpose of this study was to describe the temporal evolution of Penicillin Non-Susceptible
Streptococcus pneumoniae (PNSSP) in regards to serotype distributions and clonal diversity recovered from meningitis
cases over 17 years.
Methods: Broth microdilution was used to identify pneumococcal isolates that were PNSSP (Minimum Inhibitory
Concentration > 0.12 μg/ml). The annual incidence rate of meningitis cases was calculated. Serotyping was defined using
multiplex polymerase chain reaction assays and quellung reaction. Genetic diversity of PNSSP isolates was assessed using
both pulsed-field gel electrophoresis (PFGE) and Multilocus Sequence Typing (MLST) analyses.
Results: A total of 854cerebrospinal fluid (CSF) culture pneumococcal isolates were tested by broth microdilution
method and serotyped. A total of 173 (20.3 %) were penicillin non-susceptible (PNSSP) (Minimum Inhibitory
concentration ≥ 0.12 μg/ml). The annual incidence of meningitis cases declined from 1.65/100,000 population
(1996) to 0.2/100,000 population in 2012 and the rate due to PNSSP declined 82 % over the 17-years of
surveillance. PNSSP isolates were restricted to 13 serotypes, being the most common ones serotypes14 (45.1 %;
78/173), 23 F (19.1 %; 33/173), 6B (14.4 %; 25/173), 19 F (9.2 %; 16/173) and 19A (5.2 %; 9/173). Among the PNSSP
isolates, 94 % had serotypes represented in the 10-valent conjugate vaccine (PCV10). The predominant serotype
14 clonal groups were identified as PFGE group A/multilocus sequence type 66 (ST66) [35.3 % (61/173)] and PFGE
group GK/ST156 [4.6 % (8/173)], the latter one associated with high level resistance to penicillin and ceftriaxone.
Conclusions: Our results show sustained reductions in pneumococcal meningitis cases in the Metropolitan region
of Salvador from 1996 to 2012. This might reflect a beneficial impact of conjugate vaccines. Continued surveillance
and further studies need to be conducted to better understanding on PCV10 vaccine impact.
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Background
Streptococcus pneumoniae (pneumococcus) often resides
asymptomatically as part of human upper respiratory
tract microbiota. It is an opportunistic pathogen that
causes infections leading to otitis media, pneumonia, sepsis
and meningitis [1]. The World Health Organization esti-
mated that this agent caused476,000 deaths among children
less than 5 years in 2008; most of these deaths occur in de-
veloping countries [2]. Furthermore, antibiotic resistance
which has been shown to be associated with a limited
spectrum of serotypes, commonly responsible for invasive
disease, may have adverse impact on the epidemiology of
pneumococcal disease [3]. Resistant pneumococci have
been isolated in all continents. In several settings over 40 %
of clinical isolates exhibit multidrug-resistance [4].
The emergence of S.pneumoniae with reduced suscepti-
bility to penicillin has been observed in Brazil [5] and in
many parts of the world. In addition, reduced susceptibility
to extended-spectrum cephalosporins such as ceftriaxone
has become a serious problem because it limits the avail-
able treatment options for pneumococcal invasive diseases
[6]. Penicillin-non-susceptible isolates have been identified
among 15 % of the pneumococcal meningitis isolates
reported in Salvador, Bahia since 1996 [7]. These isolates
are restricted to five serotypes (14, 19A, 19 F, 23 F and 6B).
Serotype 14was the main penicillin-non-susceptible sero-
type within this area, as it was in the U.S. prior to PCV7
implementation [8], and has disseminated to widely separ-
ate geographic areas [3].
Widespread use of PCV7 dramatically affect the epi-
demiology of invasive pneumococcal disease (IPD) and
carriage reservoir [9, 10]. The Ministry of Health incor-
porated PCV7in Brazil in 2001 for groups with special
clinical conditions considered at high risk of IPD, as im-
munodeficiency, asplenia and severe cardio-pulmonary
diseases, who received vaccination at special immuno-
biological reference center and at private clinics. In 2010,
nationwide PCV10vaccination started for children less
than 2 years of age through the national immunization
program [11].
Pneumococcal clones have been shown to switch
their capsular serotype by exchanging genetic material
with other pneumococci; such changes could affect the
ability of conjugate vaccines to control disease and
could alter the relationship between antimicrobial
resistance and serotype [1, 3]. Pneumococcal strain
surveillance over time is essential to determine the
relative importance of established and emerging
antimicrobial-resistant clonal complexes [8]. So far,
few publications have addressed the distribution of
pneumococcal penicillin non-susceptible clonal com-
plexes in Latin America [7]. Here we describe the tem-
poral incidence, serotype distributions and genotype
diversity of penicillin-nonsusceptible S.pneumoniae
(PNSSP) strains recovered from meningitis cases from
1996 through 2012.
Methods
Study population and surveillance system
Active surveillance for pneumococcal meningitis was
established at the Hospital Couto Maia, a state infectious
disease hospital with 120 beds, which serves as the refer-
ence center for meningitis in the Salvador Metropolitan
region (3,573,973 inhabitants). The state health department
requires that all suspected meningitis cases from inside the
metropolitan region are referred to that hospital, and more
than 95 % of the meningitis reports from the region are re-
ported from that site [12]. From January 1996 to December
2012, our study team reviewed the daily clinical laboratory
records at the hospital to identify all patients for whom
cerebrospinal fluid cultures yielded S.pneumoniae.
Clinical and epidemiological data collection
For all identified pneumococcal meningitis patients who
were admitted to the surveillance hospital, a standardized
data entry form was used to extract demographic and
clinical information from their medical records. After their
cases were identified, patients were interviewed to obtain
information regarding potential risk factors for acquiring
penicillin-non-susceptible pneumococci, such as acute
illness preceding meningitis and comorbidities.
Laboratory procedures
Identification and susceptibility testing
The pneumococcal isolates identified in this hospital were
sent to the Laboratory of Pathology and Molecular Biology
at the Gonçalo Moniz Research Center CPqGM/FIOCRUZ
for confirmation. The microbiological testing to confirm
the S.pneumoniae isolates were performed by standard
methods, including Gram stain, colony morphology on agar
media with 5 % of sheep blood, optochin susceptibility
(5 μg Oxoid disks) and bile solubility. The broth micro-
dilution method was performed according to Clinical and
Laboratory Standard Institute recommendations to deter-
mine the susceptibility of the isolates to penicillin,
ofloxacin, cefotaxime, clindamycin, chloramphenicol,
erythromycin, tetracycline, rifampicin, TMP-SXZ, and
vancomycin (Sigma–Aldrich, Germany). Quality con-
trol was performed by testing the S. pneumoniae ATCC
49619 isolate. The current CLSI criteria were applied
for susceptibility interpretation. According to the CLSI
breakpoints for parenteral penicillin (meningitis), all
isolates with MIC value ≥0.12 μg/mL were defined as
PNSSP [13].
Determination of capsular serotypes
From 1996 to 2005, pneumococcal strains were serotyped
by the Quellung reaction with capsular type-specific anti-
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pneumococcal sera at the Centers for Disease Control and
Prevention (CDC). After 2006, capsular serogroups/
serotypes were deduced using multiplex-PCR as described
elsewhere [14, 15]. All isolates identified as serogroup 6 in
the multiplex-PCR were subjected to wciN6C–specific
PCR, as previously described, for the identification of
potential serotype 6C and 6D isolates [16]. Isolates with
negative or equivocal multiplex PCR results were subjected
to Quellung reaction testing for capsular type definition at
the CDC.
Molecular typing
Briefly, total DNA was extracted and digested with SmaI,
and the DNA fragments were resolved by PFGE as
described previously [17]. The Gel Compar software
package (version 4.0; Applied Maths, Bionumerics) was
used to compare the band patterns. PFGE patterns were
clustered by the unweighted-pair group method using
average linkages (UPGMA), and a dendrogram was
generated from a similarity matrix calculated using the
Dice similarity coefficient, with an optimization of 1.0 %
and a tolerance of 1.5 %. PFGE patterns were defined as
isolates with a similarity of 80 % or higher in the
dendrogram.
MLST was performed as previously described [18]
on representative isolates according to the following
criteria: (i) a minimum of two isolates from each PFGE
pattern containing 10 or more isolates were selected,
(ii) a minimum of one isolate from each PFGE pattern
containing two to nine isolates was selected and, (iii)
for a randomly selected group of 23 isolates with unre-
lated PFGE patterns.
The sequence types (STs) were obtained with reference at
the MLST database (http://pubmlst.org/spneumoniae/) and
the alternatives primers recommended by CDC (http://
www.cdc.gov/streplab/alt-MLST-primers.html). New allelic
profiles have been submitted to the MLST database for
ST assignment.
Clonal Complex (CC) are groups of STs which share a
recent common ancestor. goeBURST was used to estimate
the relationships among the different STs. goeBURST isa
java implementation of the eBURST algorithm rules pro-
posed by Feil et al, 2004 [19] that uses a graphic matrix
approach to ensure an optimal solution for the placement
of links between STs.Version 1.2.1of the software was used
(http://goeburst.phyloviz.net).
Data analysis
A clinical and epidemiological database was created and
analyzed with Epi-Info Version 3.5.1 (CDC, Atlanta,
GA). We calculated annual incidence rates (cases per
100,000 population) by dividing the number of cases
among residents of the Metropolitan Region of Salvador
(MRS) by the estimated population, using 2000 census
bureau (3,021,572 population) to calculate rates for 1996
through 2007; for 2008 through 2012, we used the 2010
census estimate of the population (3,573,973 population)
[20]. Fisher’s exact or chi-square tests were used to com-
pare differences between proportions for dichotomous
variables, and odds ratio (OR) and 95 % confidence
interval (CIs) were calculated as measure of association.
The chi-square test for linear trends was applied to com-
pare the fluctuations in incidence rates per year and for
comparison of PNSSP proportions. Statistical significance
was defined as p < 0.05. Univariate and multivariate logistic
regression models were constructed to identify risk factors
for invasive diseases caused by PNSSP. Multivariate analysis
was calculated using unconditional logistic regression. To
be included in this model, a variable was considered when
presented a p value less than 0.05 in univariate analysis.
Ethics statement
The study was approved by the Institutional Review
Board of the Oswaldo Cruz Foundation (FIOCRUZ),
Brazilian Ministry of Health and Hospital Couto Maia.
Patients were enrolled in the study according to in-
formed consent procedures. All patients or legal guard-
ian gave written informed consent prior to enrolling in
the study.
Results
Surveillance for penicillin nonsusceptible pneumococcal
meningitis
A total of 917 patients with S. pneumoniae meningitis
were consecutively identified at the surveillance
hospital during 17 years of laboratory-based active
surveillance. Pneumococcal isolates were available for
characterization for 854/917 (93.1 %) cases. Considering
that 489 patients resided within the Metropolitan Salvador,
the annual incidence of pneumococcal meningitis declined
from 1.65/100,000 population (1996) to 0.2/100,000 popu-
lation in 2012. We identified 173/854 (20.3 %) isolates as
PNSSP. On the basis of 101(58 %) cases that occurred in
patients who resided in MRS and had isolates with penicil-
lin MIC ≥ 0.12 μg/mL, the annual incidence for PNSSP
was estimated to be 0.3 case per100,000 population
(1996) declined by 82 % in 17-years of surveillance,
ranging from 0.3 to 0.06 cases per 100,000 population
[p < 0.001] (Fig. 1).
Patient characteristics
Of the 844 patients for whom demographic information
was available, 317 (37.6 %) were children aged < 5 years
and 542 (64.2 %) were male. Of the 173 cases that were
penicillin non-susceptible, 61.1 % occurred in children
less than 5 years of age (p < 0.05) (Table 1) and 49.1 %
occurred in children aged < 2 years. A clinical presenta-
tion of meningitis preceded by pneumonia was associated
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with isolates non-susceptible to penicillin (p = 0.03) in
univariate analysis (Table 1). The overall case fatality ratio
was 30.3 %. After adjusting in multivariate analyses, risk
factor for having meningitis due to PNSSP was age less
than five years old (OR, 4.2; 95 % CI, 2.1-8.4).
Antibiotic susceptibility and serotype distribution
All 854 isolates were submitted for antibiotic suscep-
tibility testing and serotyping. All isolates were
susceptible to vancomycin, and ≥98 % of isolates were
susceptible to ofloxacin, cefotaxime, erythromycin,
clindamycin, chloramphenicol, and rifampicin. Overall,
20.3 % (n = 173) of isolates were PNSSP, 48 % (n = 410) to
TMP-SXZ, and 27 % (n = 230) to tetracycline. The PNSSP
isolates were commonly non-susceptible to TMP-SXZ
(138/173, 79.8 %) and tetracycline (27/173, 15.6 %) and
less commonly non-susceptible to cefotaxime (7/173,
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Fig. 1 Incidence of pneumococcal meningitis cases in the metropolitan region os Salvador from 1996 to 2012. Abbreviations: Total cases (TOTAL),
pneumococcal non-susceptible to penicillin (PNSSP)
Table 1 Characteristics of patients with pneumococcal meningitis, stratified by penicillin susceptibility
Characteristics Penicillin non-susceptible(n = 173) Penicillin Susceptible(n = 681) OR 95 % CI p value









671 424 (63.2 %) 1.32 [0.92–1.90] 0.13
Age 162 651
<5 years 99 (61.1 %) 218 (33.5 %) 4.2 [2.1–8.4]2 <0.05
≥5 years 63 (38.9 %)
Neurological condition at
admission1
104 81 (77.9 %) 356 289 (81.2 %) 0.82 [0.47–1.40] 0.45
Acute illness preceding meningitis 61 177
Pneumonia 7 (11.5 %) 7 (3.9 %) 3.15 [1.05–9.37] 0.03
AOM 9 (14.8 %) 31 (17.5 %) 0.81 [0.36–1.82] 0.61
URTI 13 (21.3 %) 38 (21.5 %) 0.99 [0.48–2.01] 0.97
ICU admission 86 38 (44.2 %) 282 137 (48.6 %) 0.84 [0.50–1.36] 0.47
>10 days of hospitalization 157 94 (59.9 %) 643 413 (64.2 %) 0.83 [0.58–1.18] 0.30
Death 160 64 (40 %) 645 195 (30.2 %) 1.54 [1.07–2.20] 0.01
Note. Data are no. (%) of patients for whom information were obtained, ICU intensive care unit, AOM Acute Otitis Media, URTI Upper Respiratory Tract Infection
1Coma/Altered mental status. 2 Adjusted odds ratio
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0.6 %). Resistance to ≥ 3 antibiotics was found in four dif-
ferent serotypes (14, 6B, 23 F and 19 F) (Table 2). Only
ten isolates (5.8 %, 10/173) had a high level of resistance
to penicillin (three isolates had MIC = 2 μg/mL and seven
isolates had MIC ≥ 4 μg/mL). Six of these penicillin re-
sistant strains were also resistant to cefotaxime (MIC ≥
1 μg/mL). The prevalence of PNSSP isolates increased
from 18.8 % in 1996 to 33.3 % in 2012 (chi-square for
linear trend = 14.5; p < 0.001) (Fig. 2).
Fifty six capsular serotypes were found among the
pneumococcal isolates identified during surveillance.
Prevalent serotypes included 14 (12 %), 3 (7.7 %), 6B
(7.4 %), 19 F (7.3 %), 23 F (6.6 %), 18C (5.3 %), 4 (4.4 %),
6A (3.4 %), 10A (2.9 %), and 8 (2.4 %). Together, these
10 serotypes represented 512 (60 %) of the isolates. The
overall percentage of capsular types included in the
PCV10 vaccine accounted for 50.5 %. A total of 13 differ-
ent serotypes were identified among the PNSSP isolates.
The most frequent were 14 (45.1 %; 78/173), 23 F (19.1 %;
33/173), 6B (14.4 %; 25/173), 19 F (9.3 %; 16/173) and 19A
(5.2 %; 9/173) (Fig. 3a). With the exception of 19 F, all of
these serotypes were significantly associated with penicillin
non-susceptibility: 14 (OR, 14.14; 95 % CI, 9.05–22.09),
23 F (OR, 5.49; 95 % CI, 3.20–9.32), 6B (OR, 2.49; 95 % CI,
1.47–4.20) and 19A (OR, 4.07; 95 % CI, 1.60-10.42). Only
three serotypes identified among the PNSSP isolates
(19A, 12 F and 13) are not represented in the PCV10.
The proportions of PCV10 serotypes among the
PNSSP isolates were 94 % (163/173). PCV10 projected
coverage was 47.9 % (78/163) and 55.2 % (90/163) of
PNSSP isolated from patients <2 and < 5 years of age,
respectively.
Molecular typing
A total of 173 PNSSP isolates were analyzed by PFGE
and 138were analyzed by MLST. We identified 19 PFGE
groups that ranged in isolate number from 2 to 61. A
total of 16.8 % (28/173) of the isolates had a single
electrophoretic profile. The distribution of the major
PFGE clonal groups (composed of 3 or more isolates)
is presented in Fig. 3b. Among these, clonal group A
was the largest group with 35.3 % (61/173) of the
Table 2 Characteristics of penicillin non-susceptible pneumococcal
isolates from meningitis cases identified from 1996 through 2012
Serotype Antibiotic resistance N° of isolates PFGE profile ST
VT 14 TMP-SXZ, TET 60 A 66
CEF 7 GK 156
6B TMP-SXZ, CLI, TET 8 AV 751
ERI, RIF 3 N 4980
19 F TMP-SXZ, TET 2 DM 177
TMP-SXZ 1 GK 156
23 F TMP-SXZ, TET, CLI 10 GA 338
TET, CLO 5 BZ 8080
9 N TMP-SXZ 1 GA 737
7C TMP-SXZ 1 A 66




NVT 6C TMP-SXZ 1 FV 2777
23B TMP-SXZ 1 AK 3536
1 FP 8089
13 TMP-SXZ 1 GD 8094
Note: VT –PCV10 Vaccine Type; NVT –Non PCV10 Vaccine Type; cefotaxime
(CEF), clindamycin (CLI), chloramphenicol (CLO), erythromycin (ERI),
tetracycline (TET), rifampicin (RIF), trimethoprim-sulfamethoxazole (TMP-SXZ)

































































Fig. 2 Proportion of penicillin susceptible (Pen_S) and non-susceptible (PNSSP) pneumococcal isolates from 1996 through 2012
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isolates. This clonal group was comprised primarily of
serotype 14 isolates and classified as ST66; the second most
common group was PFGE type GK /ST 156 with eight
isolates, which were mainly serotype 14 (7) and 19 F(1) and
resistant to penicillin (MIC range from 2 to 8 μg/mL) and
cefotaxime (MIC range 1 to 4 μg/mL). Serotype 23 F also
was commonly associated with resistance and was com-
pounded by PFGE type GA/ST 338(10 isolates) followed by
PFGE type BZ/ST 8080 (5 isolates) and PFGE type BJ/ST
8083 (3 isolates). Serotype 6Bclustered in three mainly
PFGE/MLST types, being PFGE type AV/ST 751 (8
isolates), PFGE type CF/ST4980 (4 isolates) and PFGE type
N/ST750 (3 isolates) (Table 1). Additionally, no new
genotype was identified within a 2-year period after
PCV-10 introduction into the childhood immunization
program, at least among PNSSP from meningitis cases.
The diversity of the 138 PNSSP isolates and the 8
PMEN international clones was visualized with the
goeBURST analysis (Fig. 4). As shown in Fig. 4, the STs
found in the population of PNSSP isolates were highly
diverse and grouped into 24 clusters. The most fre-
quent sequence type among the PNSSP isolates was
ST66 serotype 14. This clonal group was also persist-
ent over the 17 years of surveillance.
Discussion
Since the identification of the first penicillin non-


















































































































Fig. 3 Distribution of most frequent PNSSP serotypes (a) and clones (b) from meningitis cases identified from1996 through2012. Note (Fig. 3b):
Others, includes all PFGE patters with 2 or less isolates
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surveys have reported that up to 20 % of pneumococcal
meningitis isolates with decreased penicillin suscepti-
bility [22, 23]. Our data indicate that the proportion of
PNSSP in meningitis cases has been fairly stable, with
an average of 20.3 % of pneumococcal isolates being
non-susceptible to penicillin. In contrast, the pneumo-
coccal meningitis epidemiology continuously changed
during the past 17 years in Salvador Metropolitan area.
One of the most important changes was the sustained
decrease in the incidence rate observed from 1996 to
2012.
In Brazilian nationwide surveillance from 1993 to
2004, an increase of penicillin non-susceptibility was
observed (10 % to 28 %), with 6 % of the isolates
displaying a high level of resistance [24]. According to
Brandileone MCC et al (2006), there are geographic
differences between PNSSP isolates in this country.
Between 2000 and 2005, in the northeastern region, the
proportion of PNSSP isolates was 20 %. The southern and
southeastern regions had a higher percentage of PNSSP
isolates (28 %) and the lowest rate in the north region was
8 %[24].
The penicillin resistance rate in Brazil was lower than
other Latin America countries, including Colombia,
Bolivia, Mexico and Venezuela, which reported rates
above 30 % [25]. In contrast, Japan have reported even
higher proportion of PNSSP (76.6 %) [26].
Additionally, we observed that a high proportion of iso-
lates were non-susceptible to antibiotics commonly used in
outpatient settings for acute respiratory infection treat-
ments in Brazil. For example, the proportion of TMP-SXZ
non-susceptible isolates reached 72 % in 2006 and keep a
rate around 50 % until 2012. In Asian countries invasive
pneumococcal isolates remained highly resistant to
macrolides, tetracycline, and TMP-SXZ each year [27].
In this study setting, we found a lower proportion
(0.6 %) of isolates resistant to erythromycin in com-
parison with developed countries [28, 29] other Latin
American countries [30] and wealthier regions within
Brazil [31]. This may be due to the relatively high cost
of macrolides, which limits its use in clinical practice
in low income population settings.
Serotype distribution information is essential in evaluat-
ing the potential benefits of pneumococcal conjugate
vaccines, particularly in developing countries where the
cost of newly available polysaccharide capsule-protein
conjugate vaccines is high relative to the available health-
care resources. Our findings regarding serotype distribu-
tions confirm those from national surveys that indicated
that a limited spectrum of serotypes were responsible for
the majority of meningitis cases due to PNSSP isolates in
Brazil. In general, serotypes 14, 23 F, 6B, 19 F and 19A were
the most frequent among the PNSSP isolates observed in
our study. These results are similar to those reported in
Fig. 4 Clonal groups of most frequent PNSSP from meningitis cases. The PMEN- Double Locus Variant clonal groupsofthe138meningitis cases
PNSSP isolates and clones (as characterized by MLST). Fifty ST’s were identified and classified into 24 groups. The size of the nodes was
proportional to the number of isolates presenting that ST in the database. The ST nodes included: Light green - Group founder; Light blue-
Common node; Black - Link drawn without recourse to tiebreak rules; Blue - Link drawn using tiebreak rule 1 and Gray - Link drawn for higher
levels (DLV with darker gray or TLV with lighter gray)
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other regions in Brazil [32, 33] and in other Latin American
countries [6]. Serotype 14 was the most common serotype,
which accounted for 44.8 % of the total PNSSP isolates.
Additionally, serotypes 23 F, 6B and 19 F are important
reservoirs of PNSSP in this setting.
In 2010, PCV10 was introduced country wide for
children less than 2 years of age in as part of Brazil’s
national immunization program. Recently, the effect-
iveness of PCV10 in Brazil was evaluating by a
case-control study, which demonstrated that PCV10
prevents invasive disease caused by vaccine serotypes,
in agreement with our finds in this study [34]. How-
ever, evaluation of the serotype distribution showed
that serotypes 14, 6B, 23 F, 18C and 19 F remain
among the most frequent serotypes causing invasive
disease two years after vaccine introduction. As only
two years post-vaccination was evaluated (and consid-
ering the lower vaccine uptake observed in some
places), there may not have been sufficient time to
observe the protection effect in all population.
The largest represented clonal group (PFGE pattern A)
comprised 35 % of the penicillin non-susceptible isolates.
This group mainly included serotype 14 (ST66), which is
a single locus variant of the ST67, Tennessee14-18clone.
ST66 is predominant throughout Brazil and is an im-
portant factor for maintaining the penicillin resistance
rate [33]. Another important clonal group of serotype 14
is ST156, which emerged in 2001 and had an elevated
MIC to penicillin and cefotaxime, this clonal group is a
serotype switch variant of clone Spain 9V - 3. ST156 has
been associated with a broad variety of serotypes includ-
ing 6B, 9A, 11A, 14, 15B/15C, 19A, 19 F, 23 F, and 24 F,
suggesting a high propensity for recombination events
[35]. This clonal complex associated with serotype 14
has been encountered in multiple countries including
Norway, France, Spain, and the United States [1, 3, 8]. It
is also very important to point out the circulation of
Colombia23F-26 clone, ST338. This clonal group has also
been reported in several countries [30, 36, 37]. Apart
from these three clonal groups, the specific clonal
structure of the PNSSP isolates was dominated by a few
other clones (Fig. 4), highlighting 24 new STs. Such a
high genetic diversity seems to be a characteristic of
PNSSP clonal complexes in general [1].
Serotype and genotype prevalence fluctuations can
occur naturally in pneumococcal populations in the
absence of pressure exerted by conjugate vaccines. In
the United States, clonal expansion (the increase in the
number of previously rare clones that express non-
vaccine serotypes) has been documented since the intro-
duction of the heptavalent conjugate vaccine (PCV-7).
Non-vaccine serotypes were increasingly a cause of
disease in the United States in the post-PCV7 era, most
frequently serotype 19A, which is associated with
antimicrobial resistance [37]. In Salvador, similar to the
findings of others, a relatively small number of serotypes
accounted for the majority of the PNSSP isolates, which
resulted in an estimated PCV10 coverage of 94 % among
those infected with PNSSP.
One of the main limitations of this study is the fact
that all S. pneumoniae were isolated from meningitis
cases. Information regarding other IPD manifestations in
our region is often limited or unavailable. Although all
of the pneumococcal isolates included in this study
originated from only one hospital, Hospital Couto Maia
is the state reference hospital in the city of Salvador,
with about 95 % of the meningitis reports from the
region originating from that site [12].
Conclusions
Our results show sustained reductions in pneumococcal
meningitis cases in the Metropolitan region of Salvador
from 1996 to 2012, with a decrease of 82 % in the incidence
of cases due to penicillin nonsusceptible pneumococci. In
this setting, 94 % of PNSSP isolates were serotypes repre-
sented in the 10-valent pneumococcal conjugate vaccine.
Although nationwide PCV10 vaccination just started in
2010, PCV7 has been available in private clinics and CRIEs
nationwide since 2001, which may have contributed to the
observed reductions on the incidence of pneumococcal
meningitis cases. Furthermore no new serotype or genotype
was observed after PCV10 implementation. However, the
circulation of non-vaccine PNSSP types as well as capsule
switching may compromise the effect of the conjugate
vaccine in the future and highlights the need for the
constant surveillance of circulating PNSSP isolates.
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